Mechanism of a Herbal Formula Associated with Prognosis and Immune Infiltration in LIHC: Transcriptomics Analysis and Molecular Dynamics Simulations

Figure 6

The drug-compound-target-disease network of STRGD for the treatment of LIHC. Nodes represent compounds and targets. The node below indicates the 148 active compounds and the colors represent different component sources. The node enclosed in a circle indicates 165 LIHC disease targets, in which blue is the co-expressed gene obtained from WGCNA and red is DEGS. The red edges represent the interaction between the compounds and the targets; the blue edges symbolize the interaction between the targets.